The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets.
 
John Bartlett
Honoraria - Oncology Education
Consulting or Advisory Role - BioNTech; bioTheranostics; Insight Genetics; True North Therapeutics
Research Funding - Genoptix; MammaPrint; NanoString Technologies; Stratifyer GmbH
Patents, Royalties, Other Intellectual Property - John Bartlett currently has 7 pending patents: 1. Methods and Devices for Predicting Anthracycline Treatment PCT/CA2015/050660, 2. Method and Apparatus for Predicting Risk in Breast Cancer US62/085,416, 3. Methods and Devices for Predicting Anthracycline (Inst)
 
Irina Kalatskaya
No Relationships to Disclose
 
Fouad Yousif
No Relationships to Disclose
 
Jane Bayani
No Relationships to Disclose
 
Quang M Trinh
No Relationships to Disclose
 
Lawrence Heisler
No Relationships to Disclose
 
Lee Timms
No Relationships to Disclose
 
Shawna Lee
No Relationships to Disclose
 
Nicholas Buchner
No Relationships to Disclose
 
Marija Milacic
No Relationships to Disclose
 
Karen Rothfels
No Relationships to Disclose
 
Cheryl Crozier
No Relationships to Disclose
 
Camilla Drake
No Relationships to Disclose
 
Annette Hasenburg
No Relationships to Disclose
 
Dirk G Kieback
No Relationships to Disclose
 
Daniel Rea
No Relationships to Disclose
 
John McPherson
No Relationships to Disclose
 
Paul Christopher Boutros
Patents, Royalties, Other Intellectual Property - Holds patents on multiple biomarkers
 
Lincoln D Stein
No Relationships to Disclose